Amylyx Pharmaceuticals Cash Flow Statement (2021-2025) | AMLX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -14.52M-21.92M-23.14M-28.34M-47.85M-54.09M-53.76M-43.80M1.57M22.07M20.89M4.51M-118.79M-72.70M-72.70M-37.17M-35.91M-41.44M-34.39M
Depreciation and Depletion 0.01M0.01M0.01M0.02M0.04M0.10M0.17M0.18M0.20M0.28M0.30M0.30M0.32M0.21M0.22M0.16M0.16M0.14M0.12M
Share-based Compensation 0.59M0.66M0.80M1.09M4.39M5.71M5.52M6.09M7.50M9.95M10.18M9.53M9.92M9.57M6.80M6.74M6.83M7.35M7.08M
Gains from Sales and Divestitures 0.15M0.16M0.17M0.19M0.23M0.26M0.69M0.71M0.70M0.78M1.16M
Gains from Investment Securities 2.00M-1.90M4.40M1.70M4.96M1.04M8.20M10.06M4.50M2.20M2.20M0.70M-1.53M1.83M9.62M5.04M
Non-cash Items 15.63M39.19M1.39M137.20M201.76M127.49M3.17M3.53M27.64M0.69M5.15M2.58M3.67M4.09M4.87M5.05M
Cash from Operations -12.64M-13.05M-20.86M-28.24M-40.63M-46.46M-43.08M-49.70M-5.07M8.61M-5.17M13.55M-0.49M-66.58M-41.57M-59.01M-39.82M-25.25M-30.37M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.10M-0.00M0.11M0.09M1.86M2.90M1.98M2.48M2.57M2.58M3.18M2.31M1.79M1.70M1.52M1.24M
Depreciation & Amortization (CF) 0.01M0.01M0.01M0.02M0.04M0.10M0.17M0.18M0.20M0.28M0.30M0.30M0.30M0.20M0.20M0.20M0.20M0.10M0.10M
Change in Working Capital
Change in Receivables 15.17M2.25M15.92M-4.12M10.70M-19.70M-16.26M-2.36M-1.28M-0.15M-0.20M0.03M
Change in Inventory 9.21M13.30M19.33M14.01M26.48M9.25M
Change in Account Payables 0.18M-1.05M0.16M1.39M5.02M-1.26M-1.10M-0.80M4.61M13.84M-18.39M15.82M-0.65M-16.43M-3.49M1.47M1.87M-1.53M-0.03M
Change in Accured Expenses 13.02M2.74M2.04M5.65M2.18M-1.21M-0.15M20.77M-7.78M-12.53M-13.11M-26.39M-11.88M5.40M1.09M
Other Working Capital Changes 0.24M0.42M1.10M2.72M4.89M-0.84M-1.17M2.34M2.88M-1.56M6.28M-4.37M2.10M-3.76M-3.84M0.51M-0.67M-5.86M3.22M
Investing Activities
Capital Expenditures 0.01M0.15M0.19M0.34M1.10M0.46M0.62M0.25M0.28M0.36M0.36M0.07M0.09M-0.02M0.02M0.01M0.02M0.02M
Change in Acquisitions & Divestments 24.91M36.00M84.50M34.00M66.00M123.50M56.70M147.92M74.00M130.00M75.00M65.00M60.00M62.00M64.00M
Cash from Investing Activities -0.01M-49.21M2.81M-99.31M4.46M84.04M-228.18M55.99M123.22M-108.09M20.93M0.82M-28.96M38.82M64.98M-43.66M22.99M5.24M
Financing Activities
Other financing activities 3.44M
Cash from Financing Activities 25.93M1.99M131.65M-1.06M200.46M-0.83M232.16M1.04M1.38M0.89M0.23M0.13M0.03M0.08M0.11M65.66M-0.03M191.61M
Additional items
Exchange Rate Effect 0.00M0.01M-0.07M-0.14M-0.37M0.51M0.07M-0.02M-0.13M0.24M-0.11M-0.04M0.24M-0.53M0.20M0.61M0.15M
Change in Cash 13.27M-11.05M61.58M-26.49M60.44M-42.96M40.59M-45.21M52.04M133.20M-112.50M34.94M0.35M-95.55M-2.44M5.56M-17.62M-1.68M166.62M
Beginning Cash Balance -13.27M11.05M-61.58M76.68M49.96M110.40M67.14M107.73M62.53M114.56M247.76M135.26M170.20M170.55M74.28M71.83M77.39M59.76M58.55M
Free Cash Flow -12.66M-13.05M-21.02M-28.43M-40.98M-47.57M-43.54M-50.32M-5.32M8.33M-5.53M13.20M-0.56M-66.67M-41.55M-59.03M-39.84M-25.27M-30.39M
Net Cash Flow 13.27M-11.05M61.58M-26.50M60.51M-42.83M40.96M-45.72M51.96M133.22M-112.37M34.71M0.46M-95.51M-2.67M6.08M-17.82M-2.29M166.47M